Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 9, Number 12—December 2003

Research

Mycobacterium tuberculosis Beijing Genotype1

Troels Lillebaek*Comments to Author , Åse B. Andersen†, Asger Dirksen‡, Judith R. Glynn§, and Kristin Kremer¶
Author affiliations: *National Institute for Prevention and Control of Infectious Diseases and Congenital Disorders, Copenhagen, Denmark; †Rigshospitalet University Hospital, Copenhagen, Denmark; ‡Gentofte University Hospital, Gentofte, Denmark; §London School of Hygiene and Tropical Medicine, London, United Kingdom; ¶National Institute of Public Health and the Environment, Bilthoven, the Netherlands

Main Article

Table 2

Proportion of patients with drug-resistant strains

N % Drug resistant (no. of patients with drug resistance)a
Any drug Isoniazid Rifampicin Streptomycin Pyrazinamide Ethambutol MDRb









Danish








Beijing
16
12.5 (2)
12.5 (2)
6.3 (1)
12.5 (2)
0.0 (0)
6.3 (1)
6.3 (1)
Other
1,623
10.2 (165)
3.1 (50)
0.12 (2)
3.6 (58)
5.5 (89)
0.0 (0)
0.0 (0)
p

0.7
0.09
0.03
0.1
1.0
0.01
0.01









Immigrants








Beijing
78
20.5 (16)
9.0 (7)
0 (0)
16.7 (13)
1.3 (1)
1.3 (1)
0.0 (0)
Other
2,086
17.2 (359)
7.5 (157)
0.72 (15)
13.6 (284)
1.3 (27)
0.96 (20)
0.58 (12)
p

0.4
0.7
1.0
0.4
1.0
0.5
1.0









Overall








Beijing
94
19.2 (18)
9.6 (9)
1.1 (1)
16.0 (15)
1.1 (1)
2.1 (2)
1.1 (1)
Other
3,709
14.1 (524)
5.6 (207)
0.46 (17)
9.2 (342)
3.1 (116)
0.54 (20)
0.32 (12)
p 0.2 0.1 0.4 0.05 0.5 0.1 0.3

aDrug resistance data missing for 41 persons.
bMDR, multidrug resistant.

Main Article

1Troels Lillebaek was responsible for the grant preparation, study design, execution, data analysis, and writing. Asger Dirksen and Åse B. Andersen supervised all parts of the study and contributed, with Judith Glynn and Kristin Kremer, critical revisions of the paper.

TOP